The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma

<div>Kaplan-Meier curves for overall survival (OS) according to the aGPS in patients with pretreatment EBV DNA &lt;4.82 × 10<sup>4</sup> copies/mL (a) and in those with pretreatment EBV DNA ≥4.82 × 10<sup>4</sup> copies/mL (b).</div>

Disease Markers

fig3

Figure 3

Figure 3: The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma 

Figure 3 | The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma 